Clinical Trial Update: DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau [Phase 1]

View source ↗

Summary

Nuravax, Inc. is conducting a Phase 1 vaccine study (DUVAX) for Alzheimer's disease that targets amyloid-beta and tau, and the trial is currently not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Preclinical Alzheimer Disease

Drugs mentioned

• DUVAX

Snippet

Sponsor: Nuravax, Inc. | Conditions: Alzheimer Disease, Alzheimer Disease (AD) | Phase 1 | Status: NOT_YET_RECRUITING